Clinical Trial Details

EORTC-55891

Back to Clinical Trials Database

Phase II study of etoposide in patients with recurrent or advanced granulosa-theca cell tumor of the ovary

Study documentation

Trial Status All trial activities ended
Dates Date of activation: 15-Aug-1989
Date Step1 close: 03-May-1993
Data management at EORTC Yes
Design Phase 2
Randomized open label
Targeted Sample size EORTC Groups: 50
Treatment
Study Staff
Type of cancer
Participating groups
Protocol summary http://clinicaltrials.gov/study/
NCT number